Haemostasis Devices Market SWOT and PEST Analysis 2031
The Haemostasis Devices Market is expected to register a CAGR of 5.8% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The report is segmented by Type (Vascular Closure Devices, Compression Devices). Futher, it is segmented based on End User (Hospitals, Clinics, Independent Diagnostic Laboratories, Others). The global analysis is further broken-down at regional level and major countries. The report offers the value in USD for the above analysis and segments.
Purpose of the ReportThe report Haemostasis Devices Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Haemostasis Devices Market Segmentation
Type- Vascular Closure Devices
- Compression Devices
- Hospitals
- Clinics
- Independent Diagnostic Laboratories
- Others
Strategic Insights
Haemostasis Devices Market Growth Drivers- Growing Surgical Procedures: The upward trend in surgical procedures worldwide is the most significant growth factor for the haemostasis devices market. The more surgeries carried out, the higher will be the demand for efficient management solutions in addressing haemostasis; hence, advanced devices with effective blood control and better patient outcomes before and after surgeries would increase its adoption rates.
- Technological Advancements: Advances in the technology of haemostasis, such as the development of automated as well as minimally invasive devices, are widely promoting the market. All these advances are improving efficacy and reducing complications, thus enhancing quicker recovery times of the patients, and the healthcare facilities are being encouraged towards new technologies, thus boosting the growth of the overall market.
- Increasing Cases of Trauma and Injuries: With the increasing number of trauma patients and cases of injury, especially in emergency departments, there will be an increased demand for haemostasis devices. Critical requirements for the management of blood flow in dangerous situations will propel the advanced haemostasis device market toward significant growth.
- Shift Toward Point-of-Care Solutions: The scope of point-of-care haemostasis solutions is on the rise, meaning immediate evaluation and management of bleeding can be achieved. Other devices, now highly sought after in healthcare facilities due to their real-time testing and rapid interventions in case of emergencies, are improving patient care and enhancing operational efficiency in health facilities.
- AI and Robotics Integration: With the trend toward artificial intelligence and robotics, it has introduced these technologies to haemostasis devices such that it enhances precision in blood control, automating procedures, which will have better outcomes and efficiency. In due time, these advanced technologies will revolutionize practices in the management of haemostasis.
- Sustainability Initiatives: In this regard, sustainability becomes inevitable in the health care sector as well as in the haemostasis devices market. There is a focus on application development by manufacturers using eco-friendly materials and practices while maintaining performance and safety standards catering to an environmentally conscious consumer base and regulatory requirements.
- Growing Awareness and Training: To ensure effective haemostasis during medical procedures, there is growing awareness among medical professionals. Better curriculum courses for the usage of haemostasis devices are encouraging adoption, which in turn enhances patient care and further fuels growth in this market.
- Collaboration with Academic Institutes: Academic institutions can be partners when coming up with innovative solutions that will lead to research and development in haemostasis. Together, product development and clinical validation can be accomplished, and knowledge can be exchanged, which makes companies better equipped to remain ahead of the competition while meeting a changing market need for such new products in the market.
- Combination Devices Development: This kind of combination devices with the integrated function of haemostasis offers unique opportunities. Combination products which integrate functionalities of several surgical instruments with haemostasis are appealing because they might possibly reduce the clutter of instruments and improve the efficacy of a surgical procedure, thus attracting healthcare providers who look for holistic solutions in an operating room settings.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Haemostasis Devices Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Haemostasis Devices Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Roche, Beckman Coulter, and Cook Medical are some of the major players operating in the market.
The report provides an extensive qualitative and quantitative analysis of the current trends and future estimations of the global haemostasis devices market from 2021 to 2031, and it also determines the prevailing opportunities.
Asia Pacific region accounted for the highest CAGR in the haemostasis devices market.
The major factors driving the haemostasis devices market are:
1. Growing Surgical Procedures.
2. Increasing Cases of Trauma and Injuries.
North America region dominated the haemostasis devices market in 2023.
The Haemostasis Devices Market is estimated to witness a CAGR of 5.8% from 2023 to 2031
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Haemostasis Devices Market - By Type
1.3.2 Haemostasis Devices Market - By End User
1.3.3 Haemostasis Devices Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. HAEMOSTASIS DEVICES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. HAEMOSTASIS DEVICES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. HAEMOSTASIS DEVICES MARKET - GLOBAL MARKET ANALYSIS
6.1. HAEMOSTASIS DEVICES - GLOBAL MARKET OVERVIEW
6.2. HAEMOSTASIS DEVICES - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. HAEMOSTASIS DEVICES MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. VASCULAR CLOSURE DEVICES (VCD)
7.3.1. Overview
7.3.2. Vascular Closure Devices (VCD) Market Forecast and Analysis
7.4. COMPRESSION DEVICES
7.4.1. Overview
7.4.2. Compression Devices Market Forecast and Analysis
8. HAEMOSTASIS DEVICES MARKET - REVENUE AND FORECASTS TO 2028 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. CLINICS
8.4.1. Overview
8.4.2. Clinics Market Forecast and Analysis
8.5. INDEPENDENT DIAGNOSTIC LABORATORIES
8.5.1. Overview
8.5.2. Independent Diagnostic Laboratories Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. HAEMOSTASIS DEVICES MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Haemostasis Devices Market Overview
9.1.2 North America Haemostasis Devices Market Forecasts and Analysis
9.1.3 North America Haemostasis Devices Market Forecasts and Analysis - By Type
9.1.4 North America Haemostasis Devices Market Forecasts and Analysis - By End User
9.1.5 North America Haemostasis Devices Market Forecasts and Analysis - By Countries
9.1.5.1 United States Haemostasis Devices Market
9.1.5.1.1 United States Haemostasis Devices Market by Type
9.1.5.1.2 United States Haemostasis Devices Market by End User
9.1.5.2 Canada Haemostasis Devices Market
9.1.5.2.1 Canada Haemostasis Devices Market by Type
9.1.5.2.2 Canada Haemostasis Devices Market by End User
9.1.5.3 Mexico Haemostasis Devices Market
9.1.5.3.1 Mexico Haemostasis Devices Market by Type
9.1.5.3.2 Mexico Haemostasis Devices Market by End User
9.2. EUROPE
9.2.1 Europe Haemostasis Devices Market Overview
9.2.2 Europe Haemostasis Devices Market Forecasts and Analysis
9.2.3 Europe Haemostasis Devices Market Forecasts and Analysis - By Type
9.2.4 Europe Haemostasis Devices Market Forecasts and Analysis - By End User
9.2.5 Europe Haemostasis Devices Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Haemostasis Devices Market
9.2.5.1.1 Germany Haemostasis Devices Market by Type
9.2.5.1.2 Germany Haemostasis Devices Market by End User
9.2.5.2 France Haemostasis Devices Market
9.2.5.2.1 France Haemostasis Devices Market by Type
9.2.5.2.2 France Haemostasis Devices Market by End User
9.2.5.3 Italy Haemostasis Devices Market
9.2.5.3.1 Italy Haemostasis Devices Market by Type
9.2.5.3.2 Italy Haemostasis Devices Market by End User
9.2.5.4 Spain Haemostasis Devices Market
9.2.5.4.1 Spain Haemostasis Devices Market by Type
9.2.5.4.2 Spain Haemostasis Devices Market by End User
9.2.5.5 United Kingdom Haemostasis Devices Market
9.2.5.5.1 United Kingdom Haemostasis Devices Market by Type
9.2.5.5.2 United Kingdom Haemostasis Devices Market by End User
9.2.5.6 Rest of Europe Haemostasis Devices Market
9.2.5.6.1 Rest of Europe Haemostasis Devices Market by Type
9.2.5.6.2 Rest of Europe Haemostasis Devices Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Haemostasis Devices Market Overview
9.3.2 Asia-Pacific Haemostasis Devices Market Forecasts and Analysis
9.3.3 Asia-Pacific Haemostasis Devices Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Haemostasis Devices Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Haemostasis Devices Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Haemostasis Devices Market
9.3.5.1.1 Australia Haemostasis Devices Market by Type
9.3.5.1.2 Australia Haemostasis Devices Market by End User
9.3.5.2 China Haemostasis Devices Market
9.3.5.2.1 China Haemostasis Devices Market by Type
9.3.5.2.2 China Haemostasis Devices Market by End User
9.3.5.3 India Haemostasis Devices Market
9.3.5.3.1 India Haemostasis Devices Market by Type
9.3.5.3.2 India Haemostasis Devices Market by End User
9.3.5.4 Japan Haemostasis Devices Market
9.3.5.4.1 Japan Haemostasis Devices Market by Type
9.3.5.4.2 Japan Haemostasis Devices Market by End User
9.3.5.5 South Korea Haemostasis Devices Market
9.3.5.5.1 South Korea Haemostasis Devices Market by Type
9.3.5.5.2 South Korea Haemostasis Devices Market by End User
9.3.5.6 Rest of Asia-Pacific Haemostasis Devices Market
9.3.5.6.1 Rest of Asia-Pacific Haemostasis Devices Market by Type
9.3.5.6.2 Rest of Asia-Pacific Haemostasis Devices Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Haemostasis Devices Market Overview
9.4.2 Middle East and Africa Haemostasis Devices Market Forecasts and Analysis
9.4.3 Middle East and Africa Haemostasis Devices Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Haemostasis Devices Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Haemostasis Devices Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Haemostasis Devices Market
9.4.5.1.1 South Africa Haemostasis Devices Market by Type
9.4.5.1.2 South Africa Haemostasis Devices Market by End User
9.4.5.2 Saudi Arabia Haemostasis Devices Market
9.4.5.2.1 Saudi Arabia Haemostasis Devices Market by Type
9.4.5.2.2 Saudi Arabia Haemostasis Devices Market by End User
9.4.5.3 U.A.E Haemostasis Devices Market
9.4.5.3.1 U.A.E Haemostasis Devices Market by Type
9.4.5.3.2 U.A.E Haemostasis Devices Market by End User
9.4.5.4 Rest of Middle East and Africa Haemostasis Devices Market
9.4.5.4.1 Rest of Middle East and Africa Haemostasis Devices Market by Type
9.4.5.4.2 Rest of Middle East and Africa Haemostasis Devices Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Haemostasis Devices Market Overview
9.5.2 South and Central America Haemostasis Devices Market Forecasts and Analysis
9.5.3 South and Central America Haemostasis Devices Market Forecasts and Analysis - By Type
9.5.4 South and Central America Haemostasis Devices Market Forecasts and Analysis - By End User
9.5.5 South and Central America Haemostasis Devices Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Haemostasis Devices Market
9.5.5.1.1 Brazil Haemostasis Devices Market by Type
9.5.5.1.2 Brazil Haemostasis Devices Market by End User
9.5.5.2 Argentina Haemostasis Devices Market
9.5.5.2.1 Argentina Haemostasis Devices Market by Type
9.5.5.2.2 Argentina Haemostasis Devices Market by End User
9.5.5.3 Rest of South and Central America Haemostasis Devices Market
9.5.5.3.1 Rest of South and Central America Haemostasis Devices Market by Type
9.5.5.3.2 Rest of South and Central America Haemostasis Devices Market by End User
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL HAEMOSTASIS DEVICES MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. HAEMOSTASIS DEVICES MARKET, KEY COMPANY PROFILES
12.1. HOFFMANN-LA ROCHE LTD.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BECKMAN COULTER, INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. HEMCON MEDICAL TECHNOLOGIES, INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. THERMO FISHER SCIENTIFIC, INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. MEDTRONIC PLC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. TRINITY BIOTECH PLC
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. COOK MEDICAL
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. SIEMENS AG
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. MEDLINE
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. INTEGRA LIFE SCIENCES CORPORATION
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. Hoffmann-La Roche Ltd.
2. Beckman Coulter, Inc.
3. HemCon Medical Technologies, Inc.
4. Thermo Fisher Scientific, Inc.
5. Medtronic Plc
6. Trinity Biotech Plc
7. Cook Medical
8. Siemens AG
9. Medline
10. Integra Life Sciences Corporation
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For